Coronary artery revascularization in patients with diabetes mellitus

EJ Armstrong, JC Rutledge, JH Rogers - Circulation, 2013 - Am Heart Assoc
1676 Circulation October 8, 2013 have been demonstrated in both rat23 and human studies
after angioplasty in type 2 DM. 24, 25 Increased neointimal hyperplasia in the diabetic artery …

Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting

D Aronson, ER Edelman - Reviews in endocrine and metabolic disorders, 2010 - Springer
Patients with diabetes mellitus (DM) are prone to a diffuse and rapidly progressive form of
atherosclerosis, which increases their likelihood of requiring revascularization. However, the …

Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention …

AP Kappetein, SJ Head, MC Morice… - European Journal of …, 2013 - academic.oup.com
OBJECTIVES This prespecified subgroup analysis examined the effect of diabetes on left
main coronary disease (LM) and/or three-vessel disease (3VD) in patients treated with …

Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents

AP Banning, S Westaby, MC Morice… - Journal of the American …, 2010 - jacc.org
Objectives: This study was designed to compare contemporary surgical revascularization
(coronary artery bypass graft surgery [CABG]) versus TAXUS Express (Boston Scientific …

5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo …

PW Serruys, Y Onuma, S Garg, P Vranckx… - Journal of the American …, 2010 - jacc.org
Objectives: The purpose of this study is to compare the 5-year clinical outcomes, safety, and
efficacy of sirolimus-eluting stents (SES) in the ARTS II (Arterial Revascularization Therapies …

Rethinking composite end points in clinical trials: insights from patients and trialists

JM Stolker, JA Spertus, DJ Cohen, PG Jones, KK Jain… - Circulation, 2014 - Am Heart Assoc
Background—Many clinical trials use composite end points to reduce sample size, but the
relative importance of each individual end point within the composite may differ between …

[HTML][HTML] Aortic no-touch technique makes the difference in off-pump coronary artery bypass grafting

MY Emmert, B Seifert, M Wilhelm… - The Journal of Thoracic …, 2011 - Elsevier
OBJECTIVES: Both off-pump surgery (OPCAB) and aortic no-touch technique reduce stroke
after coronary artery bypass grafting (CABG). We evaluate the impact of partial aortic …

The DELTA 2 registry: a multicenter registry evaluating percutaneous coronary intervention with new-generation drug-eluting stents in patients with obstructive left …

A Chieffo, A Tanaka, G Giustino, I Briede… - JACC: Cardiovascular …, 2017 - jacc.org
Objectives: The aim of this study was to evaluate clinical outcomes of unprotected left main
coronary artery percutaneous coronary intervention (PCI) with new-generation drug-eluting …

Is off-pump superior to conventional coronary artery bypass grafting in diabetic patients with multivessel disease?

MY Emmert, SP Salzberg, B Seifert… - European journal of …, 2011 - academic.oup.com
Objective: Diabetic patients often present with diffuse coronary disease than nondiabetic
patients posing a greater surgical challenge during off-pump revascularization. In this study …

Long-term comparison of drug-eluting stents and coronary artery bypass grafting for multivessel coronary revascularization: 5-year outcomes from the Asan Medical …

DW Park, YH Kim, HG Song, JM Ahn, J Oh… - Journal of the American …, 2011 - jacc.org
Objectives: We performed the long-term (5-year) follow-up of a large cohort of patients who
underwent drug-eluting stent (DES) or coronary artery bypass graft (CABG) surgery for …